HAIR LIGHT

GOAL

Evaluation of the feasibility and efficacy of photobiomodulation therapy in the prevention and management of chemotherapy-induced alopecia.

STUDY DESIGN

Controlled and randomized trial with patients undergoing chemotherapy in the Jessa Hospital. This trial started in February 2022.

PBM group (n=36)	Control group (n=36)
Scalp cooling during their chemotherapy and PBM (3x/week) during their chemotherapy and until one month post chemotherapy	Scalp cooling during their chemotherapy

STUDY RESULTS

Study is still active and no preliminary results are available.

PUBLICATIONS

 

PARTNERS